相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Urine neopterin in childhood acute demyelinating diseases: Potential for differential diagnosis
Meltem Yildiz Kayaoglu et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)
Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls
Anna Olsson et al.
FRONTIERS IN IMMUNOLOGY (2021)
Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis
Niklas Joisten et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis
Cecilia Rajda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
Yi-Shu Huang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis
Lorenzo Gaetani et al.
FRONTIERS IN IMMUNOLOGY (2020)
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
Tamas Biernacki et al.
CELLS (2020)
Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression
Gayathri Sundaram et al.
JOURNAL OF NEUROINFLAMMATION (2020)
A validated UHPLC-MS method for tryptophan metabolites: Application in the diagnosis of multiple sclerosis
Ferenc Tomosi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2020)
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Clare Walton et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Inflammation in cancer and depression: a starring role for the kynurenine pathway
Luca Sforzini et al.
PSYCHOPHARMACOLOGY (2019)
Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis
Stephanie Herman et al.
CELLS (2019)
Immunoregulatory Interplay Between Arginine and Tryptophan Metabolism in Health and Disease
Giada Mondanelli et al.
FRONTIERS IN IMMUNOLOGY (2019)
Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis
Vanessa X. Tan et al.
FRONTIERS IN NEUROSCIENCE (2019)
Kynurenine System and Multiple Sclerosis, Pathomechanism and Drug Targets with An Emphasis on Laquinimod
Zsofia Majlathi et al.
CURRENT DRUG TARGETS (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis
Laura Negrotto et al.
JOURNAL OF IMMUNOLOGY (2017)
Indoleamine-2,3-dioxygenase(IDO)2 polymorphisms are not associated with multiple sclerosis in Italians
Cristina Agliardi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases
Michael D. Lovelace et al.
NEUROPHARMACOLOGY (2017)
Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment
Monika Adamczyk-Sowa et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression
Chai K. Lim et al.
SCIENTIFIC REPORTS (2017)
The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO
Giada Mondanelli et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature
Ahmad Nejati et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2016)
Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms
Shahin Aeinehband et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Current evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
Michael D. Lovelace et al.
FRONTIERS IN IMMUNOLOGY (2016)
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System
Cecilia Rajda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
The kynurenine pathway and neurodegenerative disease
Daniel C. Maddison et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis
Roberta Mancuso et al.
PLOS ONE (2015)
Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies
Gayathri Sundaram et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research
Nam Trung Nguyen et al.
FRONTIERS IN IMMUNOLOGY (2014)
Kynurenines in the CNS: recent advances and new questions
Laszlo Vecsei et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Oxidative modification of serum proteins in multiple sclerosis
Izabela Sadowska-Bartosz et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Sustained Elevation of Kynurenic Acid in the Cerebrospinal Fluid of Patients with Herpes Simplex Virus Type 1 Encephalitis
Ann Atlas et al.
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2013)
The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications
Judit Fuevesi et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Control of immune response by amino acid metabolism
Ursula Grohmann et al.
IMMUNOLOGICAL REVIEWS (2010)
The Importance of NAD in Multiple Sclerosis
W. Todd Penberthy et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Interferon-γ and Tumor Necrosis Factor-α Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-Guerin
Jason C. O'Connor et al.
JOURNAL OF NEUROSCIENCE (2009)
Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis
J. M. Anderson et al.
BRAIN (2008)
Activation of myelin reactive T cells in multiple sclerosis: A possible role for T cell degeneracy?
Piet Stinissen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis
Richard A. O'Connor et al.
JOURNAL OF IMMUNOLOGY (2008)
Characterization of the kynurenine pathway in human neurons
Gilles J. Guillemin et al.
JOURNAL OF NEUROSCIENCE (2007)
IDO and regulatory T cells:: a role for reverse signalling and non-canonical NF-κB activation
Paolo Puccetti et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis
K. Rejdak et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders
Katalin Sas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Kynurenine pathway in major depression:: Evidence of impaired neuroprotection
Aye-Mu Myint et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Epidemiology of headache in Europe
LJ Stovner et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Kynurenine metabolism in multiple sclerosis
Z Hartai et al.
ACTA NEUROLOGICA SCANDINAVICA (2005)
Interferon-β affects the tryptophan metabolism in multiple sclerosis patients
A Amirkhani et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Age-related increase of kynurenic acid in human cerebrospinal fluid-IgG and beta(2)-microglobulin changes
B Kepplinger et al.
NEUROSIGNALS (2005)
Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden
YM Huang et al.
MULTIPLE SCLEROSIS (2005)
pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I
Q Han et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
AβI-42 induces production of quinolinic acid by human macrophages and microglia
GJ Guillemin et al.
NEUROREPORT (2003)
Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients
K Rejdak et al.
NEUROSCIENCE LETTERS (2002)
T cell apoptosis by tryptophan catabolism
I Fallarino et al.
CELL DEATH AND DIFFERENTIATION (2002)
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
G Frumento et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells:: Mediation of suppression by tryptophan metabolites
P Terness et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis
K Sakurai et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
IFN-β1b induces kynurenine pathway metabolism in human macrophages:: Potential implications for multiple sclerosis treatment
GJ Guillemin et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
GJ Guillemin et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Oligodendrocyte killing by quinolinic acid in vitro
W Cammer
BRAIN RESEARCH (2001)
The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1α and-1β in macrophages
MC Bosco et al.
JOURNAL OF IMMUNOLOGY (2000)
Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis
GJ Guillemin et al.
REDOX REPORT (2000)
分享论文
